ALUNBRIG’s intracranial efficacy

Takeda Presents New Data Highlighting Scientific Advancements in Lung Cancer at ESMO Virtual Congress

Osaka, Japan & Cambridge, Mass., United States:  − Key Results from Phase 3 ALTA 1L Sub-Analyses Further Support ALUNBRIG’s Strong Intracranial…

Read More »